Connect your AI

AtriCure ATRC Operating Lease Liability Payments - 2024 (Lessee)

Operating Lease Liability Payments - 2024 (Lessee) at other companies

AbbottABT

——

Pacira BioSciences, Inc.PCRX

——

Other financials

Income statement

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

Market cap$1.43B-7.9%

Enterprise value$1.36B-11.2%

P/S2.6×-0.6×

Profitability

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's operating lease liability payments - 2024 (lessee).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AtriCure's operating lease liability payments - 2024 (lessee)?: AtriCure (ATRC) reported operating lease liability payments - 2024 (lessee) of $1.48M in Q1 2026.
How has AtriCure's operating lease liability payments - 2024 (lessee) changed year-over-year?: AtriCure's operating lease liability payments - 2024 (lessee) decreased by 10.8% year-over-year, from $1.65M to $1.48M.